(continued)
- Idelvion (Factor IX, Recombinant/Albumin Fusion Protein)
- Hemlibra (Emicizumab-kxwh)
- Wilate (Antihemophilic Factor/von Willebrand Factor Complex)
- Humate P (Antihemophilic Factor/von Willebrand Factor Complex)
- Alphanate (Antihemophilic factor/von Willebrand Factor Complex)
- Denosumab (Osenvelt, Wyost, Xgeva)
- Besremi (Ropeginterferon Alfa-2b-Njft)
- Dasatinib (Sprycel, Phyrago)
- Imatinib (Gleevec, Imkeldi)
- Cabometyx (Cabozantinib)
- Cometriq (cabozantinib)
- Cometriq (cabozantinib)
- Tretinoin (Vesanoid)
- Revuforj (Revumenib)
- Vanflyta (quizartinib)
- Vizimpro (dacomitinib)
- Xospata (Gilteritinib)
- Rozlytrek (entrectinib)
- Vitrakvi (larotrectinib)
- Caprelsa (Vandetanib)
- Zynteglo (betibeglogene autotemcel)
- Lyfgenia (lovotibeglogene autotemcel)
- Lapatinib (Tykerb)
- Pazopanib (Votrient)
- Hemofil M (antihemophilic factor, human)
- Tukysa (Tucatinib)
- Turalio (Pexidartinib)
- Sorafenib (Nexavar)
- Iclusig (Ponatinib)
- Esperoct (antihemophilic factor, recombinant)
- How Does Enhertu Work for Breast Cancer?
- How Pluvicto Fights Prostate Cancer and What to Expect